New rabies vaccine trial aims to save lives with stronger protection
NCT ID NCT07500207
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new rabies vaccine in 3,000 healthy people aged 10 to 60. The goal is to see how well it triggers the body's defenses and if it's safe. The vaccine is given in different schedules to find the best way to prevent rabies after a possible exposure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RABIES PREVENTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
sichuan CDC
Neijiang, Sichuan, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.